JP2014201567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014201567A5 JP2014201567A5 JP2013080906A JP2013080906A JP2014201567A5 JP 2014201567 A5 JP2014201567 A5 JP 2014201567A5 JP 2013080906 A JP2013080906 A JP 2013080906A JP 2013080906 A JP2013080906 A JP 2013080906A JP 2014201567 A5 JP2014201567 A5 JP 2014201567A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- active ingredient
- cashew
- food composition
- kashuimo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 8
- 244000226021 Anacardium occidentale Species 0.000 claims 5
- 235000020226 cashew nut Nutrition 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 244000061456 Solanum tuberosum Species 0.000 claims 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims 3
- -1 n Species 0.000 claims 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 2
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000006866 deterioration Effects 0.000 claims 2
- 230000004217 heart function Effects 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 230000028327 secretion Effects 0.000 claims 2
- 239000002830 appetite depressant Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080906A JP2014201567A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080906A JP2014201567A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014201567A JP2014201567A (ja) | 2014-10-27 |
| JP2014201567A5 true JP2014201567A5 (enExample) | 2016-06-30 |
Family
ID=52352330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013080906A Pending JP2014201567A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2014201567A (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4021505B2 (ja) * | 1995-03-27 | 2007-12-12 | 徹 赤羽 | 糖尿病治療薬及び機能性食品 |
| JP2002154978A (ja) * | 2000-11-17 | 2002-05-28 | Uma:Kk | 血糖降下物質及びその機能性食品 |
| JP2005008572A (ja) * | 2003-06-19 | 2005-01-13 | Yakult Honsha Co Ltd | リパーゼ阻害剤 |
| JP5794678B2 (ja) * | 2010-06-16 | 2015-10-14 | 株式会社東洋新薬 | グルカゴン様ペプチド−1分泌促進剤 |
| JP2012131742A (ja) * | 2010-12-22 | 2012-07-12 | Kao Corp | Glp−1分泌促進剤 |
-
2013
- 2013-04-09 JP JP2013080906A patent/JP2014201567A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4501932A3 (en) | Kras g12c inhibitors | |
| DOP2018000182A (es) | Benzamidas sustituidas con 1,3tiazol2ilo | |
| FI3328843T3 (fi) | 1,3,4-oksadiatsolisulfonamidijohdannaisyhdisteitä histonideasetylaasi-6:n inhibiittoreina ja samaa käsittävä farmaseuttinen koostumus | |
| MA55571A (fr) | Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
| WO2012051318A8 (en) | Sulphonamide compounds and methods of making and using same | |
| WO2012177757A3 (en) | Personal care compositions comprising shaped abrasive particles | |
| EA201190145A1 (ru) | Фармацевтические композиции, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления | |
| EP4335418A3 (en) | Compositions and methods for treating pterygium | |
| WO2013103919A8 (en) | Compositions and methods for treating metabolic disorders | |
| EP3808367A3 (en) | Targeting aneurysm disease by modulating phagocytosis pathways | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| WO2016149501A3 (en) | Modified therapeutic agents and compositions thereof | |
| AU2014375637A1 (en) | Formula of neuregulin preparation | |
| FR3024037B1 (fr) | Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques | |
| PL3232780T3 (pl) | Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie | |
| BR112012019351A2 (pt) | composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica. | |
| WO2016040169A3 (en) | Mucolytic agents for use in tretaing pulmonary sarcoidosis | |
| MX2017002968A (es) | Anticuerpo monoclonal humanizado para inhibir la actividad enzimatica de la lipasa endotelial vascular. | |
| IL269884B1 (en) | Gamkaban its accepted pharmaceutical salts, their compositions and methods of their use | |
| CR20160353A (es) | Inhibidor de proteína de transferencia del éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden el inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares | |
| PL3019182T3 (pl) | Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania | |
| JP2014201567A5 (enExample) | ||
| WO2012102560A3 (ko) | 신규한 4-o-메틸호노키올 유도체 및 이를 유효성분으로 포함하는 염증질환 치료용 조성물 | |
| JP2014101346A5 (enExample) | ||
| JP2014201568A5 (enExample) |